Molecular epidemiology of prostate cancer: androgens and polymorphisms in androgen-related genes.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  European Journal of Endocrinology

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1530/EJE.0.1490469PMID 14640986
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of polymorphisms within androgen receptor, 5 alpha-reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men.

  2003cited by this paper
• SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis.

  2003cited by this paper
• Association of the CYP17 gene polymorphism with the risk of prostate cancer: a meta-analysis.

  2003cited by this paper
• Androgens and prostate cancer

  2003cited by this paper
• Polymorphic CAG/CAA repeat length in the AIB1/SRC-3 gene and prostate cancer risk: a population-based case-control study.

  2002influential reference
• A polymorphism in the CYP17 gene and risk of prostate cancer.

  2002cited by this paper
• Steroid 5-alpha reductase type II V89L substitution is not associated with risk of prostate cancer in a multiethnic population study.

  2002influential reference
• 5alpha-reductase 2 polymorphisms as risk factors in prostate cancer.

  2002influential reference
• Association of polymorphisms within androgen receptor-5alfa-reductase- and PSA-genes with prostate volume, clinical parameters and endocrine status in elderly men

  2002cited by this paper
• Polymorphic CAG repeats in the androgen receptor gene, prostate-specific antigen polymorphism and prostate cancer risk.

  2002influential reference
• Evidence for an Association between the SRD5A2 (Type II Steroid 5α-Reductase) Locus and Prostate Cancer in Italian Patients

  2002influential reference
• Androgen receptor CAG polymorphism and prostate cancer risk

  2002influential reference
• Hormones and prostate cancer: Current perspectives and future directions

  2002influential reference
• Association of polymorphisms within androgen receptor, 5α‐reductase, and PSA genes with prostate volume, clinical parameters, and endocrine status in elderly men

  2002cited by this paper
• Androgen receptor polymorphisms and the incidence of prostate cancer.

  2002influential reference
• Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.

  2002influential reference
• Polymorphic GGC repeats in the androgen receptor gene are associated with hereditary and sporadic prostate cancer risk

  2002influential reference
• The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.

  2001influential reference
• V89L polymorphism of type-2, 5-alpha reductase enzyme gene predicts prostate cancer presence and progression.

  2001influential reference
• Prostate carcinoma risk and allelic variants of genes involved in androgen biosynthesis and metabolism pathways

  2001influential reference
• A case–control study of the androgen receptor gene CAG repeat polymorphism in Australian prostate carcinoma subjects

  2001influential reference
• Are serum hormones associated with the risk of prostate cancer? Prospective results from the Massachusetts Male Aging Study.

  2001cited by this paper
• A missense substitution A49T in the steroid 5-alpha-reductase gene (SRD5A2) is not associated with prostate cancer in Finland

  2001influential reference
• Replication validity of genetic association studies

  2001cited by this paper
• Cyp17 promoter variant associated with prostate cancer aggressiveness in African Americans.

  2001influential reference
• Impact of genetic polymorphisms of 17‐hydroxylase cytochrome P‐450 (CYP17) and steroid 5α‐reductase type II (SRD5A2) genes on prostate‐cancer risk among the Japanese population

  2001influential reference
• The association between polymorphisms in the CYP17 and 5alpha-reductase (SRD5A2) genes and serum androgen concentrations in men.

  2001cited by this paper
• A common promotor variant in the cytochrome P450c17alpha (CYP17) gene is associated with bioavailability testosterone levels and bone size in men.

  2001cited by this paper
• A Common Promoter Variant in the Cytochrome P450c17α (CYP17) Gene Is Associated with Bioavailable Testosterone Levels and Bone Size in Men

  2001cited by this paper
• NF-1C, Sp1, and Sp3 are essential for transcription of the human gene for P450c17 (steroid 17alpha-hydroxylase/17,20 lyase) in human adrenal NCI-H295A cells.

  2001cited by this paper
• Tandem CAG repeats of the androgen receptor gene and prostate cancer risk in black and white men

  2001cited by this paper
• Linkage and association of CYP17 gene in hereditary and sporadic prostate cancer

  2001influential reference
• Allelic variants of aromatase and the androgen and estrogen receptors: toward a multigenic model of prostate cancer risk.

  2001influential reference
• Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.

  2001influential reference
• Hormones and prostate cancer: what's next?

  2001cited by this paper
• Molecular epidemiology of hormone-metabolic loci in prostate cancer.

  2001cited by this paper
• Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene.

  2000cited by this paper
• Amplified in breast cancer-1 glutamine repeat and prostate cancer risk

  2000influential reference
• A polymorphism in the CYP17 gene is associated with prostate cancer risk

  2000influential reference
• International trends and patterns of prostate cancer incidence and mortality

  2000influential reference
• Reproducibility studies and interlaboratory concordance for androgen assays in female plasma.

  2000cited by this paper
• Breast cancer susceptibility gene 1 (BRCAI) is a coactivator of the androgen receptor.

  2000cited by this paper
• Increased risk of prostate cancer and benign prostatic hyperplasia associated with a CYP17 gene polymorphism with a gene dosage effect.

  2000influential reference
• The polymorphic exon 1 androgen receptor CAG repeat in men with a potential inherited predisposition to prostate cancer.

  2000influential reference
• Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case-control study in China.

  2000influential reference
• Serum testosterone and sex hormone‐binding globulin concentrations and the risk of prostate carcinoma

  1999cited by this paper
• The V89L polymorphism in the 5alpha-reductase type 2 gene and risk of prostate cancer.

  1999cited by this paper
• Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

  1999influential reference
• Links between genetic and environmental factors and prostate cancer risk

  1999influential reference
• CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

  1999influential reference
• Androgen receptor polymorphisms: Association with prostate cancer risk, relapse and overall survival

  1999influential reference
• CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1.

  1999cited by this paper
• Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.

  1999influential reference
• Anti-androgens and other hormonal therapies for prostate cancer.

  1999cited by this paper
• Prostate cancer associated with CYP17 genotype.

  1999influential reference
• (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German population

  1999influential reference
• The V89L Polymorphism in the 5α-Reductase Type 2 Gene and Risk of Prostate Cancer

  1999influential reference
• The androgen receptor gene GGN microsatellite and prostate cancer risk.

  1998influential reference
• Androgen Metabolism and Prostate Cancer: Establishing a Model of Genetic Susceptibility

  1998cited by this paper
• Relationships of serum androgens and estrogens to prostate cancer risk: results from a prospective study in Finland.

  1998cited by this paper
• Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility.

  1998cited by this paper
• Genetic variation of 3β‐hydroxysteroid dehydrogenase type II in three racial/ethnic groups: Implications for prostate cancer risk

  1997cited by this paper
• 5 alpha-reductase activity and prostate cancer: a case-control study using stored sera.

  1997cited by this paper
• Aromatase in hyperplasia and carcinoma of the human prostate

  1997cited by this paper
• Androgens in serum and the risk of prostate cancer: a nested case-control study from the Janus serum bank in Norway.

  1997cited by this paper
• The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.

  1997influential reference
• A polymorphism of the 5 alpha-reductase gene and its association with prostate cancer: a case-control analysis.

  1997influential reference
• Association of prostate cancer risk with genetic polymorphisms in vitamin D receptor and androgen receptor.

  1997influential reference
• Polymorphic repeats in the androgen receptor gene: molecular markers of prostate cancer risk.

  1997influential reference
• A prevalent missense substitution that modulates activity of prostatic steroid 5alpha-reductase.

  1997cited by this paper
• Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes.

  1997cited by this paper
• Aromatase mRNA Levels in Benign Prostatic Hyperplasia and Prostate Cancer

  1996cited by this paper
• Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells.

  1996cited by this paper
• Reduced androgen receptor gene expression with first exon CAG repeat expansion.

  1996cited by this paper
• Prospective study of sex hormone levels and risk of prostate cancer.

  1996cited by this paper
• Serum androgens and prostate cancer.

  1996cited by this paper
• Longitudinal evaluation of serum androgen levels in men with and without prostate cancer

  1995cited by this paper
• The CAG and GGC microsatellites of the androgen receptor gene are in linkage disequilibrium in men with prostate cancer.

  1995influential reference
• Serum androgens and sex hormone-binding globulins in relation to lifestyle factors in older African-American, white, and Asian men in the United States and Canada.

  1995cited by this paper
• Evidence for a repressive function of the long polyglutamine tract in the human androgen receptor: possible pathogenetic relevance for the (CAG)n-expanded neuronopathies.

  1995cited by this paper
• Genetic variability of the human SRD5A2 gene: implications for prostate cancer risk.

  1995cited by this paper
• Dinucleotide repeat polymorphisms in the HSD3B2 gene.

  1994cited by this paper
• The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function.

  1994cited by this paper
• Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17.

  1994cited by this paper
• Serological precursors of cancer: serum hormones and risk of subsequent prostate cancer.

  1993cited by this paper
• Unusual length polymorphism in human steroid 5 alpha-reductase type 2 gene (SRD5A2).

  1993cited by this paper
• Unusual length polymorphism in human steroid 5α-reductase type 2 gene (SRD5A2)

  1993cited by this paper
• The relationship of serum dehydroepiandrosterone and its sulfate to subsequent cancer of the prostate.

  1993cited by this paper
• Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression.

  1993cited by this paper
• Genetic variation at five trimeric and tetrameric tandem repeat loci in four human population groups.

  1992cited by this paper
• 5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

  1992cited by this paper
• A prospective, population-based study of androstenedione, estrogens, and prostatic cancer.

  1990cited by this paper
• The early in utero oestrogen and testosterone environment of blacks and whites: potential effects on male offspring.

  1988cited by this paper
• Prediagnostic serum hormones and the risk of prostate cancer.

  1988cited by this paper
• Cloning and sequence of the human gene for P450c17 (steroid 17 alpha-hydroxylase/17,20 lyase): similarity with the gene for P450c21.

  1987cited by this paper
• Cloning and Sequence of the Human Gene for P450cl7 (Steroid 17α-Hydroxylase/17,20 Lyase): Similarity with the Gene for P450c21

  1987cited by this paper
• Characterization of the cytosol androgen receptor of the human prostate.

  1983cited by this paper
• The development of prostatic adenocarcinoma in Nb rats following prolonged sex hormone administration.

  1977cited by this paper

• Genetic associations of prostate cancer in China: a systematic review

  2025cites this paper
• World Trade Center Exposure, DNA Methylation Changes, and Cancer: A Review of Current Evidence

  2023cites this paper
• Lipopeptides in promoting signals at surface/interface of micelles: Their roles in repairing cellular and nuclear damages

  2022cites this paper
• Characterization of Mice Bearing Humanized Androgen Receptor Genes (h/mAr) Varying in Polymorphism Length

  2020cites this paper
• Androgens stimulate erythropoiesis through the DNA binding activity of the androgen receptor in non-hematopoietic cells.

  2020cites this paper
• Association between Long Non-coding RNA POLR2E rs3787016 Polymorphism and Cancer Susceptibility: A Meta-analysis of 8725 Cancer Cases and 10710 Controls

  2020cites this paper
• Polymorphism and Gene–Environment Interactions in Environmental Cancer

  2019cites this paper
• Association of Hsa-miR-23a rs3745453 variation with prostate cancer risk among Chinese Han population

  2019influential citation
• Long non-coding RNA POLR2E gene polymorphisms increased the risk of prostate cancer in a sample of the Iranian population

  2019cites this paper
• G 1733 A ( RS 6152 ) polymorphism of the androgen receptor gene in patients with prostate cancer

  2018cites this paper
• Association between three genetic variants in kallikrein 3 and prostate cancer risk

  2018cites this paper
• MiR‐206 inhibits proliferation and migration of prostate cancer cells by targeting CXCL11

  2018cites this paper
• 4‐bp insertion/deletion (rs3783553) polymorphism within the 3′UTR of IL1A contributes to the risk of prostate cancer in a sample of Iranian population

  2018cites this paper
• The Association Between Three Genetic Variants in MicroRNAs (Rs11614913, Rs2910164, Rs3746444) and Prostate Cancer Risk

  2018cites this paper
• Association of Some Polymorphisms in the VDR Gene, CYP17 Gene and SRD5A2 Gene and Prostate Cancer among Lebanese Men

  2017influential citation
• Functional polymorphism at the miR-502-binding site in the 3' untranslated region of the SETD8 gene increased the risk of prostate cancer in a sample of Iranian population.

  2017cites this paper
• 3-bp indel polymorphism (rs57408770) within pre-miR-3131 on PCa susceptibility in a sample of an Iranian population. Patients and methods

  2017cites this paper
• Evaluation of a 3-base pair indel polymorphism within pre-microRNA-3131 in patients with prostate cancer using mismatch polymerase chain reaction-restriction fragment length polymorphism.

  2017cites this paper
• Polymorphisms in androgen metabolism genes AR, CYP1B1, CYP19, and SRD5A2and prostate cancer risk and aggressiveness in Bulgarian patients.

  2016cites this paper
• Association between single nucleotide polymorphism in miR-499, miR-196a2, miR-146a and miR-149 and prostate cancer risk in a sample of Iranian population.

  2016cites this paper
• The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population

  2015cites this paper
• Polimorfismos y cáncer de próstata. Perspectiva actual

  2015cites this paper
• Mutational pattern in the 5&agr; reductase 2 (SRD5A2) gene in 46,XY Egyptian DSD patients

  2015cites this paper
• Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups.

  2015cites this paper
• Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men.

  2015cites this paper
• A Meta-Analysis of Association Between One-Carbon Metabolism Gene Polymorphisms and Risk of Prostate Cancer

  2015cites this paper
• Lack of association between CYP17 Mspa1 polymorphism and prostate cancer risk: a meta-analysis of 14494 cases and 15971 controls.

  2013cites this paper
• A2 allele polymorphism of the CYP17 gene and prostate cancer risk in an iranian population.

  2013cites this paper
• Curcumin induces cell cycle arrest and apoptosis of prostate cancer cells by regulating the expression of IkappaBalpha, c-Jun and androgen receptor.

  2013cites this paper
• Personalized Cancer Therapy for Urological Cancers: From Bench to Bedside and Back

  2012influential citation
• Effectiveness of the combined evaluation of KLK3 genetics and free-to-total prostate specific antigen ratio for prostate cancer diagnosis.

  2012cites this paper
• Proyecto de Áreas de formación profesional, presentado como requisito parcial para optar por el Grado de Licenciatura en Ciencias Biológicas y Ambientales

  2012cites this paper
• CASP8 promoter polymorphism, mRNA expression and risk of prostate cancer among Chinese men

  2011cites this paper
• A designed cell-permeable aptamer-based corepressor peptide is highly specific for the androgen receptor and inhibits prostate cancer cell growth in a vector-free mode.

  2011cites this paper
• The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases

  2011cites this paper
• Analysis of ligand-specific co-repressor binding to the androgen receptor.

  2011cites this paper
• Prostate cancer and ambient pesticide exposure in agriculturally intensive areas in California.

  2011cites this paper
• Dutasteride: novel milestones in prostate cancer chemoprevention.

  2011cites this paper
• Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

  2011cites this paper
• Androgen receptor htSNPs in relation to androgen levels and OC use in young women from high-risk breast cancer families.

  2011cites this paper
• Transgenic Adenocarcinoma of the Mouse Prostate: A Validated Model for the Identification and Characterization of Molecular Targets and The Evaluation of Therapeutic Agents

  2011cites this paper
• Prostate cancer in Asian Americans: incidence, management and outcomes in an equal access healthcare system

  2011cites this paper
• Serum sex steroids measured in middle-aged European and African-Caribbean men by gas chromatography-mass spectrometry.

  2011cites this paper
• The associations between genetic variants body composition, and blood pressure in Afro-Caribbean men from Tobago

  2010cites this paper
• Polimorfismo V89L do gene 5 α-redutase tipo II (SRD5A2) e a associação com o risco de câncer de próstata :

  2010cites this paper
• A functional polymorphism in Pre‐miR‐146a gene is associated with prostate cancer risk and mature miR‐146a expression in vivo

  2010cites this paper
• Development of a Benzopyran‐Containing Androgen Receptor Antagonist to Treat Antiandrogen‐Resistant Prostate Cancer

  2010cites this paper
• Association between polymorphisms of TP53 and MDM2 and prostate cancer risk in southern Chinese.

  2010cites this paper
• eview he natural compounds atraric acid and N-butylbenzene-sulfonamide as ntagonists of the human androgen receptor and inhibitors of prostate cancer ell growth

  2010cites this paper
• Overview of pivotal studies for prostate cancer risk reduction, past and present.

  2009cites this paper
• CYP 17 Gene Polymorphism and its Association in North Indian Prostate Cancer Patients

  2009cites this paper
• Chimeric molecules facilitate the degradation of androgen receptors and repress the growth of LNCaP cells.

  2009cites this paper
• SRD5A2 V89L polymorphism and prostate cancer risk: A meta‐analysis

  2009cites this paper
• Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer.

  2009cites this paper
• CYP17 gene polymorphism and its association in north Indian prostate cancer patients.

  2009cites this paper
• The natural compound atraric acid is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth

  2009cites this paper
• PSA and Androgen-Related Gene (AR, CYP17, and CYP19) Polymorphisms and the Risk of Adenocarcinoma at Prostate Biopsy

  2008cites this paper
• Genetic polymorphisms in CYP17, CYP3A4, CYP19A1, SRD5A2, IGF‐1, and IGFBP‐3 and prostate cancer risk in African‐American men: The Flint Men's Health Study

  2008cites this paper
• Glutamine tract length of human androgen receptors affects hormone-dependent and -independent prostate cancer in mice.

  2008cites this paper
• The androgen receptor and prostate cancer: a role for sexual selection and sexual conflict?

  2008cites this paper
• Genetic Polymorphismsin CYP 17 , CYP 3 A 4 , CYP 19 A 1 , SRD 5 A 2 , IGF-1 , and IGFBP-3 andProstateCancerRiskin African-AmericanMen : The FlintMen ’ sHealth Study

  2008cites this paper
• The presence of the CYP11A1 (TTTTA)6 allele increases the risk of biochemical relapse in organ confined and low-grade prostate cancer.

  2008cites this paper
• Étude de l'impact des récepteurs non stéroïdiens sur l'activité androgénique dans les cellules cancéreuses de la prostate

  2008cites this paper
• Dietary risk factors for prostate cancer and benign prostatic hyperplasia

  2007cites this paper
• A novel polymorphism in the 17β-hydroxysteroid dehydrogenase type 5 (aldo-keto reductase 1C3) gene is associated with lower serum testosterone levels in caucasian men

  2007cites this paper
• Pathogenesis and molecular targeted therapy of spinal and bulbar muscular atrophy

  2007cites this paper
• Alien interacts with the human androgen receptor and inhibits prostate cancer cell growth.

  2007cites this paper
• Testosterone levels in relation to oral contraceptive use and the androgen receptor CAG and GGC length polymorphisms in healthy young women.

  2007cites this paper
• CYP17 Genetic Variation and Risk of Breast and Prostate Cancer from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3)

  2007cites this paper
• The effects of aging on tumor growth and angiogenesis are tumor‐cell dependent

  2007cites this paper
• Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer

  2007cites this paper
• Factores genéticos de susceptibilidad al cáncer de tiroides y riesgo genético del tratamiento con (131)I

  2006cites this paper
• Systematic replication study of reported genetic associations in prostate cancer: Strong support for genetic variation in the androgen pathway

  2006cites this paper
• Polymorphisms in estrogen bioactivation, detoxification and oxidative DNA base excision repair genes and prostate cancer risk.

  2006cites this paper
• Award Number: W81XWH-04-1-0214 TITLE: Inhibition of Androgen-Independent Growth of Prostate Cancer by siRNA- Mediated Androgen Receptor Gene Silencing

  2006cites this paper
• CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones: A population‐based study in Shanghai, China

  2006cites this paper
• Germ-line genetic variation in the key androgen-regulating genes androgen receptor, cytochrome P450, and steroid-5-alpha-reductase type 2 is important for prostate cancer development.

  2006cites this paper
• Prevention of hormone-related cancers: prostate cancer.

  2005cites this paper
• Health-related disparities: influence of environmental factors.

  2005cites this paper
• The development of prostate cancer despite late onset androgen deficiency

  2005cites this paper
• Thyroid Cancer Susceptibility and THRA1 and BAT-40 Repeats Polymorphisms

  2005cites this paper
• Inhibition of Androgen-Independent Growth of Prostate Cancer by siRNA-Mediated Androgen Receptor Gene Silencing

  2005cites this paper
• Polymorphisms in genes associated with androgen biosynthesis and metabolism as risk factors for human prostate cancer

  2005cites this paper
• Association of GSTM1, GSTT1, and GSTP1 gene polymorphisms with the risk of prostate cancer: a meta-analysis.

  2005cites this paper
• Association of GSTM 1 , GSTT 1 , and GSTP 1 Gene Polymorphisms with the Risk of Prostate Cancer : A Meta-analysis

  2005cites this paper
• Chemoprevention: from research to clinical oncology.

  2005cites this paper
• Review article Testosterone therapy in the ageing male: what about the prostate?

  2004cites this paper
• MOLECULAR DETERMINANTS OF ANDROGEN ACTION

  2004cites this paper
• X-chromosome inactivation patterns and androgen receptor functionality influence phenotype and social characteristics as well as pharmacogenetics of testosterone therapy in Klinefelter patients.

  2004cites this paper